Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : KDUS, who knows this company? -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (78)	1/30/1998 9:00:00 PM
From: Dave K	Read Replies (1) \| Respond to of 117

Oh Oh ! At the time I was curious why SIBI issued this release the day after Cadus annnounced their MIT deal. Dave

To: scaram(o)uche who wrote (78)	1/31/1998 7:31:00 AM
From: SVogel	Read Replies (1) \| Respond to of 117

Richard, I don't mind calling the IR about the patent dispute and the possible effect on the dropping stock price--but I'd be shocked if the company did anything but dismiss this concern. I know Cadus has two issued patents and has filed for about 50 more -- with one on-going patent dispute with Sibia a looming worry. But I don't know much more than that. How do you see it? What is Cadus' stance? I'm not a lawyer, and I got interested in Cadus this past December before the Levin departure, when it was recommended by the.street's newsletter. I liked the prospects then, and I still do -- even more so, if they lock into strong CEO in time. But frankly, I've seen patent disputes over technology in other areas drag on and on and nothing comes of it. Maybe this is different. Your reasoned take would be very much appreciated. Thanks. Steve